Language
Blog
HomeHome >

Blog

LATEST NEWS
Sep 16, 2023
WHO’s first traditional medicine summit splits opinionsread more
Sep 02, 2023
Australian trade body’s new CEO calls on nutra brands selling overseas to innovate for local markets read more
Sep 02, 2023
Rivaroxaban vs Warfarin for Atrial Fibrillation in CKD Population read more
Sep 01, 2023
Epigenetic modifier modulator CSread more
Aug 31, 2023
Other news to note for Aug. 28, 2023 read more
Aug 30, 2023
FRAILread more
Aug 29, 2023
ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients read more
Aug 28, 2023
IRA’s Drug Price Negotiation Program Could Save Medicare $1.8B in First Year read more
Aug 27, 2023
Stroke, Clot Risk Halved When Apixaban Taken Versus Rivaroxabanread more
Aug 26, 2023
Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study. read more
Aug 25, 2023
WILLOW ANNOUNCES COLLABORATION WITH A LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS read more
Aug 24, 2023
GHW International Warns of Sharp Drop in H1 Profit read more
first1 2 3 4 5 6 7 last